US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist
  • 20.790
  • +0.140+0.68%
Close Nov 25 16:00 ET
  • 20.790
  • 0.0000.00%
Post 20:01 ET
13.20BMarket Cap20.42P/E (TTM)

Genmab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Genmab Q3 2024 Earnings Date

Currency：DKKNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
5.65B
5.54B
-106.47M
Miss Est.
+19.02%
+17.57%
-1.89%
EPS
2.10
1.98
-0.12
Miss Est.
-35.68%
-37.98%
-5.49%
Analyst Rating
Buy

Nov 25, 2024

Genmab Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: DKK

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.927B--
--2024/Q4-- / 6.331B--
Nov 6, 20242024/Q35.540B / 5.646B--
Aug 8, 20242024/Q25.402B / 4.959B--
May 2, 20242024/Q14.143B / 3.989B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.927B--
--2024/Q4-- / 6.331B--
Nov 6, 20242024/Q35.540B / 5.646B--
Aug 8, 20242024/Q25.402B / 4.959B--
May 2, 20242024/Q14.143B / 3.989B--

Unlock Free Earnings Estimates

Genmab Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 6 11:12 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 1 10:35 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 11 15:51 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 14 10:50 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 25, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data